Inventor
GLENN KEVIN C
US18 patents
⚠️ This page may combine multiple inventors who share the name “GLENN KEVIN C”. Patents are grouped by organization below to help distinguish them — per-person disambiguation is on the roadmap.
SEARLE & CO
6 patentsUS6943189B2Sep 13, 2005
Combination therapy employing ileal bile acid transport inhibiting benzothiepines and HMG CO-A reductase inhibitors
SEARLE & CO78 citations97
US6642268B2Nov 4, 2003
Combination therapy employing ileal bile acid transport inhibiting benzothipines and HMG Co-A reductase inhibitors
SEARLE & CO22 citations92
US6420417B1Jul 16, 2002
Combination therapy employing ileal bile acid transport inhibiting benzothiepines and HMG Co-A reductase inhibitors
SEARLE & CO37 citations92
US6268392B1Jul 31, 2001
Combination therapy employing ileal bile acid transport inhibiting benzothiepines and HMG Co-A reductase inhibitors
SEARLE & CO37 citations92
US6562860B1May 13, 2003
Combinations of ileal bile acid transport inhibitors and bile acid sequestering agents for cardiovascular indications
SEARLE & CO39 citations91
US6462091B1Oct 8, 2002
Combinations of cholesteryl ester transfer protein inhibitors and HMG coA reductase inhibitors for cardiovascular indications
SEARLE & CO15 citations84
SEARLE LLC
6 patentsUS6458851B1Oct 1, 2002
Combinations of ileal bile acid transport inhibitors and cholesteryl ester transfer protein inhibitors for cardiovascular indications
SEARLE LLC35 citations92
US6489366B1Dec 3, 2002
Combinations of cholesteryl ester transfer protein inhibitors and nicotinic acid derivatives for cardiovascular indications
SEARLE LLC6 citations73
US6569905B1May 27, 2003
Combinations of cholesteryl ester transfer protein inhibitors and bile acid sequestering agents for cardiovascular indications
SEARLE LLC4 citations62
US6458850B1Oct 1, 2002
Combinations of cholesteryl ester transfer protein inhibitors and fibric acid derivatives for cardiovascular indications
SEARLE LLC6 citations62
US6890958B2May 10, 2005
Combinations of cholesteryl ester transfer protein inhibitors and nicotinic acid derivatives for cardiovascular indications
SEARLE LLC1 citations52
US6638969B1Oct 28, 2003
Combinations of ileal bile acid transport inhibitors and fibric acid derivatives for cardiovascular indications
SEARLE LLC1 citations51
PHARMACIA CORP
3 patentsUS6605624B1Aug 12, 2003
Substituted pyridines useful for inhibiting cholesteryl ester transfer protein activity
PHARMACIA CORP23 citations90
US6794396B2Sep 21, 2004
Substituted pyridines useful for inhibiting cholesteryl ester transfer protein activity
PHARMACIA CORP13 citations82
US6627731B1Sep 30, 2003
Thrombin derived polypeptides; compositions and methods for use
PHARMACIA CORP11 citations73